# LLM call: summary

- Turn: 13
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 743
- Completion tokens: 403
- Total tokens: 1146
- Cost (USD): 0.000155

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1075: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
H1 2032: Leading foreign model cut off overnight for European users without appeal, freezing diagnostic assistants, triage, procurement forecasting built around it amid ransomware recovery; Brussels called it unilateral cutoff. Simultaneously, tailored cures for previously untreatable conditions reached routine use abroad using those models, confirmed real by EMA, sparking patient pressure. Commission invoked emergency health/crisis articles: HERA, EuroHPC, ENISA ring-fenced inference reserve, pushed clean open-weight images to hospitals/ministries, routed therapies via joint procurement with local manufacturing. Rollout faltered: thin reserve capacity, exhausted commune IT, transformer delays blocking new rack sites; large hospitals on degraded open models, small clinics waiting, daily continuity list and prioritization row returned. Automated recovery tools sped re-imaging but confidence stayed low; materials breakthrough pilots continued disconnected from wards. Net: fallback systems on paper and partial racks while others ran frontier.

CURRENT NARRATIVE:
### Rationed like everyone else
The second tightening of chip and model controls landed in autumn. Brussels had hoped for allied volume licences — continuity for hospitals, research and industry in exchange for servicing, grid equipment and evaluation capacity. Washington drew the line tighter instead. European buyers were put in the same queue as everyone else, with allocations, paperwork and quarterly review.

For the clinical reserve it was an immediate blow. Racks ordered for four university hospital hubs slipped to next year. Transformer fast-tracks helped with power, but without accelerators there was nothing to power. Procurement officers who had just relearned to live without the leading foreign model now had to learn to live with fewer chips to run its replacements.

### Two tracks, one ward
The Commission kept the hospital reserve as the operational centre. Daily continuity lists were published, clean system images pushed out, and the first tailored-therapy pilots started in a handful of wards under joint procurement with local manufacturing clauses. Large centres stabilised on degraded open models; smaller clinics still waited, and mayors quarrelled openly over the order of the list.

Alongside it, trade and foreign ministers opened the coalition track. Offers of lithography servicing, power-kit supply and shared testing capacity were taken to Washington, Tokyo, Seoul and a handful of middle powers holding chemicals and packaging. Talks were polite and slow. No carve-out was granted this year, though officials brought home language about future assurance cooperation.

By December the mood was bitter. Patients read about cures abroad while nurses rebooted assistants at home. The reserve was visibly working, but visibly second-best. The sense of being cut off, first by licence and then by allocation, settled into routine resentment.
```

## Raw response

```
H1 2032: Leading foreign model cut off overnight for European users without appeal, freezing diagnostic assistants, triage, procurement forecasting amid ransomware recovery; Brussels called it unilateral cutoff. Tailored cures for untreatable conditions reached routine use abroad, confirmed by EMA, sparking patient pressure. Commission invoked emergency articles: HERA, EuroHPC, ENISA ring-fenced inference reserve, pushed clean open-weight images, routed therapies via joint procurement with local manufacturing. Rollout faltered: thin reserve, exhausted IT, transformer delays; large hospitals on degraded open models, small clinics waiting, daily continuity list and prioritization row returned. Net: partial fallback while others ran frontier.

H2 2032: Second tightening of chip/model controls in autumn; hoped-for allied volume licences denied, Washington put European buyers in same queue with allocations and quarterly review. Clinical reserve hit: racks for four university hospital hubs slipped to next year; power fast-tracks useless without accelerators. Commission kept hospital reserve as operational centre — daily lists, clean images, first tailored-therapy pilots in handful of wards; large centres stabilised degraded, smaller clinics waited amid mayoral quarrels. Parallel coalition track offered lithography servicing, power-kits, testing capacity to Washington, Tokyo, Seoul and middle powers; polite, slow, no carve-out, only language on future assurance. Mood by December: reserve visibly working but second-best, routine resentment at double cutoff by licence then allocation.
```
